0001415889-19-000487.txt : 20190429 0001415889-19-000487.hdr.sgml : 20190429 20190429202436 ACCESSION NUMBER: 0001415889-19-000487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190429 DATE AS OF CHANGE: 20190429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASAMENTO CHARLES J CENTRAL INDEX KEY: 0001117167 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 19777928 MAIL ADDRESS: STREET 1: 99 BELBROOK WAY CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-04292019_050423.xml X0306 4 2019-03-31 0001604191 AzurRx BioPharma, Inc. AZRX 0001117167 CASAMENTO CHARLES J SUITE 304 BROOKLYN NY 11226 true false false false Common Stock 2019-03-31 4 A 0 7500 2.42 A 71500 D Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2019. /s/ Maged Shenouda, Attorney-in-Fact 2019-04-29